Hope there is enough muscle to give them a kicking. As its played out the AS witch hunt that came to largely nothing and delays in filings which subsequently has limited any offerings appears an orchestrated charade to stop the company from disclosing info in a prospectus to market that would have allowed them to raise money.
With signed bits of paper from Medimmune, Sanofi and Amgen they could have raised cash...but appears the board care more about a position in an Orbimed owned company
- Forums
- ASX - By Stock
- UNS
- Litigation Assist
Litigation Assist, page-16
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UNS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online